J&J posted $24B in Q3 sales and $2.80 adjusted EPS, beating estimates and raising full-year guidance.The post Johnson & Johnson Posts Strong Q3 with $5.15B Net Earnings, Lifts 2025 Outlook appeared first on Tokenist.